- Home
- HOUR vs ATNM Comparison
HOUR vs ATNM Comparison
Compare HOUR & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- ATNM
- Stock Information
- Founded
- HOUR 2015
- ATNM 2000
- Country
- HOUR United States
- ATNM United States
- Employees
- HOUR N/A
- ATNM N/A
- Industry
- HOUR Catalog/Specialty Distribution
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- ATNM Health Care
- Exchange
- HOUR Nasdaq
- ATNM Nasdaq
- Market Cap
- HOUR 67.5M
- ATNM 56.5M
- IPO Year
- HOUR 2022
- ATNM N/A
- Fundamental
- Price
- HOUR $1.92
- ATNM $1.17
- Analyst Decision
- HOUR
- ATNM Strong Buy
- Analyst Count
- HOUR 0
- ATNM 4
- Target Price
- HOUR N/A
- ATNM $8.75
- AVG Volume (30 Days)
- HOUR 383.8K
- ATNM 167.7K
- Earning Date
- HOUR 03-25-2025
- ATNM 03-28-2025
- Dividend Yield
- HOUR N/A
- ATNM N/A
- EPS Growth
- HOUR N/A
- ATNM N/A
- EPS
- HOUR 0.05
- ATNM N/A
- Revenue
- HOUR $143,314,112.00
- ATNM $81,000.00
- Revenue This Year
- HOUR $39.97
- ATNM $138.42
- Revenue Next Year
- HOUR N/A
- ATNM $16,957.05
- P/E Ratio
- HOUR $37.98
- ATNM N/A
- Revenue Growth
- HOUR 15.71
- ATNM N/A
- 52 Week Low
- HOUR $0.83
- ATNM $1.07
- 52 Week High
- HOUR $6.90
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- HOUR 42.92
- ATNM 46.97
- Support Level
- HOUR $1.88
- ATNM $1.15
- Resistance Level
- HOUR $1.98
- ATNM $1.29
- Average True Range (ATR)
- HOUR 0.20
- ATNM 0.07
- MACD
- HOUR -0.04
- ATNM 0.01
- Stochastic Oscillator
- HOUR 4.60
- ATNM 46.51
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.